Sayaka Namba
Overview
Explore the profile of Sayaka Namba including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
140
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fujiyoshi K, Yamaoka-Tojo M, Minami Y, Kutsuna T, Obara S, Kakizaki R, et al.
Int Heart J
. 2018 Aug;
59(5):1034-1040.
PMID: 30158387
Cognitive impairment is frequently represented in elderly patients with cardiovascular disease (CVD); yet, the mechanism is uncertain. Recent studies have suggested the association between the vascular endothelial dysfunction and cognitive...
2.
Hashikata T, Tojo T, Muramatsu Y, Sato T, Kakizaki R, Nemoto T, et al.
J Atheroscler Thromb
. 2017 Aug;
25(3):233-243.
PMID: 28824048
Aim: Fractional flow reserve (FFR) reflects on the diffuse atherosclerosis per coronary artery. It is unknown whether the statin therapy affects long term FFR after stenting. The aim of this...
3.
Namba S, Yamaoka-Tojo M, Kakizaki R, Nemoto T, Fujiyoshi K, Hashikata T, et al.
Heart Vessels
. 2017 Mar;
32(8):983.
PMID: 28314975
No abstract available.
4.
Namba S, Yamaoka-Tojo M, Kakizaki R, Nemoto T, Fujiyoshi K, Hashikata T, et al.
Heart Vessels
. 2017 Feb;
32(8):977-982.
PMID: 28233091
In recent years, direct oral anticoagulants (DOACs) of dabigatran, rivaroxaban, apixaban, edoxaban, which are all alternatives to warfarin, have been released. The use of DOACs is becoming more widespread in...
5.
Hashikata T, Yamaoka-Tojo M, Kakizaki R, Nemoto T, Fujiyoshi K, Namba S, et al.
Heart Vessels
. 2016 Apr;
32(1):47-54.
PMID: 27052207
Ezetimibe reduces plasma levels of low-density lipoprotein cholesterol by inhibiting Niemann-Pick C1-like protein 1 (NPC1L1). A recent study demonstrated that NPC1L1 plays an important role in absorption of fat-soluble vitamins...
6.
Hashikata T, Yamaoka-Tojo M, Kakizaki R, Nemoto T, Fujiyoshi K, Namba S, et al.
Heart Vessels
. 2016 Feb;
31(8):1311-1312.
PMID: 26892529
No abstract available.
7.
Namba S, Yamaoka-Tojo M, Hashikata T, Ikeda Y, Kitasato L, Hashimoto T, et al.
BBA Clin
. 2015 Dec;
4:76-80.
PMID: 26674156
Background: Stroke prevention by warfarin, a vitamin K antagonist, has been an integral part in the management of atrial fibrillation. Vitamin K-dependent matrix Gla protein (MGP) has been known as...
8.
Hashikata T, Yamaoka-Tojo M, Namba S, Kitasato L, Kameda R, Murakami M, et al.
Int Heart J
. 2015 Sep;
56(5):544-50.
PMID: 26370374
Cell migration, proliferation, and differentiation of cardiac fibroblasts (CFs) play a central role in cardiac fibrosis. Factor Xa (FXa)-dependent protease-activated receptor (PAR)-1 and PAR-2 have been reported as important targets...
9.
Hashikata T, Yamaoka-Tojo M, Kakizaki R, Nemoto T, Fujiyoshi K, Namba S, et al.
Heart Vessels
. 2015 Aug;
31(8):1303-10.
PMID: 26266630
Incretin hormones have been reported to have cytoprotective actions in addition to their glucose-lowering effects. We evaluated whether teneligliptin, a novel dipeptidyl peptidase-4 (DPP-4) inhibitor, affects left ventricular (LV) function...
10.
Kitasato L, Shimohama T, Ikeda Y, Namba S, Hashikata T, Kameda R, et al.
Biomed Pharmacother
. 2015 Jun;
72:6-10.
PMID: 26054668
Background: The target lesion revascularization of paclitaxel-eluting stents (PES) has been reported to be lower than that of sirolimus-eluting stents in patients on hemodialysis (HD). However, the comparison of PES...